Aptorum Group plans 1-for-10 reverse stock split ahead of DiamiR merger

Aptorum Group

Aptorum Group

APM

0.00
  • Aptorum will execute a 1-for-10 reverse stock split tied to its planned merger with DiamiR Biosciences, expected to close around July 20, 2026.
  • Split aims to lift the post-merger share price to support Nasdaq minimum bid compliance; the combined company is set to trade as Niki BioSolutions under “NIKI”.
  • Outstanding Class A shares to drop to about 634,682 from about 6,346,823; Class B shares to fall to about 179,693 from about 1,796,934.
  • Par value for both share classes to rise to $0.0001 from $0.00001; authorized share count to be reduced.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptorum Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607161100PRIMZONEFULLFEED9763334) on July 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.